Romidepsin - Anti-cancer

Drug Name:
Romidepsin - Anti-cancer

List Of Brands:

Indication Type Description:

Indication

Dosages/ Overdosage Etc

   

Indication:

 Proprietary  Name- Istodax
 
Established Name -  Romidepsin for Infusion- histone decacetylase (HAC) 
inhibitor
 
Applicant-   Gloucester Pharmaceuticals Inc.
 
Indication-
Cutaneous T-Cell Lymphoma (CTCL) who have received one prior
systemic therapy
 
Dosage-
14mg/m2 administered by  IV infusion over 4hr on Day 1,8,15,on a 28 day cycle
 
Approved by FDA  on 5-11-2010  (Ref- FDA approved List- 2010)